|
Investor Information
Vyteris Annouces Key Scientific Advisors 08.19.08
FAIR LAWN, N.J., Aug 19, 2008 (BUSINESS WIRE) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced the formation of a Scientific Advisory Group comprised of four renowned scientists, researchers and clinicians with ...
Vyteris Announces Launch of Initiative to Pursue Joint Development Agreements in Pain Management 08.05.08
FAIR LAWN, N.J., Aug 05, 2008 (BUSINESS WIRE) -- Vyteris, Inc. (OTC BB: VYTR), manufacturer of the first U.S. Food and Drug Administration (FDA)-approved active patch transdermal drug delivery system, announced an initiative to identify and target candidate drugs in the pain management field that could potentially be delivered using Vyteris' active...
Financial Results
|
|
| Delayed 20 minutes. |
| Last Trade: |
0.92 |
| Change: |
0.00
|
| % Change: |
0.000%
|
| Intraday Range: |
0.92 - 0.92 |
| Aug 26, 2008 9:30 AM ET |
| Stock Information >> |
|
|
|
